Adoption Increases for VeriTeQ’s “Q Inside” Breast Implant Safety Technology
VeriTeQ Corporation, a provider of implantable medical device identification and radiation dose measurement technologies, announced today that the adoption of its Q Inside Safety Technology continues to increase across Europe. There are now more than 800 women in Europe and Japan who have received Motiva Implant Matrix breast implants, manufactured by VeriTeQ’s customer Establishment Labs, S.A. (“EL”), with VeriTeQ’s Q Inside Safety Technology. Motiva Implant Matrix breast implants with Q Inside Safety Technology can be safely and accurately identified from outside of the body in a physician’s office.
VeriTeQ’s FDA cleared Q Inside Safety Technology acts as an electronic serial number in breast implants and other implantable and reusable medical devices to provide physicians and patients access to secure online databases to retrieve device-specific data, such as serial number, manufacturer name, date of manufacture, lot number, volume, size, and other data from the medical device manufacturer. Q Inside Safety Technology may also provide an extra level of protection to the patient in the event of a recall or other safety event.
EL’s Motiva Implant Matrix Ergonomix, VelvetSurface PLUS, and SilkSurface PLUS, all with VeriTeQ’s Q Inside Safety Technology, have received CE Mark approval, which enables EL to market its Motiva Implant Matrix breast implants to patients in 28 countries in the European Union.
“We are pleased with the widespread physician and patient acceptance of the combination of EL’s advanced breast implants and our important medical device identification technology,” said Scott R. Silverman, VeriTeQ’s Chairman and Chief Executive Officer. “We believe that Q Inside Safety Technology sets EL’s Motiva Implant Matrix breast implants apart from its competitors, offering distinct advantages when it comes to both patient safety and device quality.”